| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $131K | -48.7% |
| Cost of Revenue | $56K | -67.5% |
| Gross Profit | $76K | -10.9% |
| R&D Expense | $380K | +188.4% |
| SG&A Expense | $2.8M | -8.1% |
| Operating Income | -$3.1M | +0.1% |
| Income Tax | $0 | — |
| Net Income | -$3.7M | -10.9% |
| EPS (Basic) | -$0.25 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Inventory | $30K | -0.9% |
| Current Assets | $237K | -60.2% |
| Total Assets | $324K | -73.5% |
| Current Liabilities | $2.6M | +23.7% |
| Long-term Debt | $1.3M | +22.7% |
| Total Liabilities | $2.6M | +24.3% |
| Stockholders' Equity | -$2.3M | -160.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.7M | +8.3% |
| Capital Expenditures | $2K | — |
| Investing Cash Flow | -$2K | +99.7% |
| Financing Cash Flow | $1.3M | -57.2% |
| Free Cash Flow | -$1.7M | +8.2% |
| +7.4% |
| EPS (Diluted) | -$0.25 | +7.4% |